There were some impressive enterprise deployments discussed at the AppNation conference in San Francisco on Thursday.
I’ll lead off with Genentech, the Bay Area biotech firm that is now a subsidiary of Roche. Their 7,000 iPad rollout was news to me, and ranks them sixth on my list of largest iPad deployments in the world.
(View the entire list of more than 530 enterprises that have publicly-confirmed iPad deployments here).
According to mobile application team manager, Paul Lanzi, Genentech has standardized on Apple for mobile, with 17,000 iOS device users worldwide (so by inference, 10,000 iPhones, though it surprises me less and less when I hear about companies deploying iPod Touches, too). All of the Apple devices are corporate-owned, as the company doesn’t do Bring Your Own Device (BYOD). Genentech does have 15,000 BlackBerry users, but they are only allowed to do e-mail, no apps. It doesn’t support Android due to the fragmentation-related hassle. “It’s a really tricky one,” Lanzi said.
While many firms talk about how their device deployments are driven by the ROI they hope to get from using apps, Genentech is actually following through. The company has deployed 60-some apps to employees. Indeed, Genentech rolled out its first mobile Web page even before the iPhone was released, said Lanzi. “We’ve already retired some apps,” he said. Continue reading “Why This Well-Known Biotech Firm Deploys 17,000 iPads and iPhones”
Filed Under: THCBTagged: Apps, BYOD, Genentech, iPad Jan 16, 2012